Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Public ClinicalTrials.gov record NCT01528345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double Blind, Placebo Controlled, Phase II Trial Evaluating the Safety and Efficacy of Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer That Have Evidence of Disease Progression on or After Prior Endocrine Therapy
Study identification
- NCT ID
- NCT01528345
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Interventions
- Dovitinib Drug
- Dovitinib Placebo Drug
- Fulvestrant Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2012
- Primary completion
- Mar 31, 2015
- Completion
- Mar 31, 2015
- Last update posted
- Jul 10, 2016
2012 – 2015
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer and Research Centers SC | Chandler | Arizona | 85224 | — |
| Highlands Oncology Group Dept of Highlands Oncology Grp | Fayetteville | Arkansas | 72703 | — |
| City of Hope National Medical Center COH 3 | Duarte | California | 91010-3000 | — |
| University of California San Diego - Moores Cancer Center Moores UCSD Cancer Ctr. SC-1 | La Jolla | California | 92093-0658 | — |
| Cedars Sinai Medical Center Samuel Oschin Cancer Center | Los Angeles | California | 90048 | — |
| H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC | Tampa | Florida | 33612 | — |
| Oncology Specialists, SC Lutheran General Advanced Care | Park Ridge | Illinois | 60068-0736 | — |
| Indiana University Health Goshen Center for Cancer SC | Goshen | Indiana | 46526 | — |
| Nebraska Methodist Hospital Estabrook Cancer Center | Omaha | Nebraska | 68114 | — |
| Saint Barnabas Medical Center CancerCenter of Saint Barnabas | Livingston | New Jersey | 07039 | — |
| ProHealth Care | Lake Success | New York | 11042 | — |
| New York Oncology Hematology, P.C. Dept. of New York Oncology. PC | Troy | New York | 12180 | — |
| Duke University Medical Center Duke (SC) | Durham | North Carolina | 27710 | — |
| Cancer Centers of the Carolinas Dept. of CC of the Carolinas | Greenville | South Carolina | 29605 | — |
| Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2) | San Antonio | Texas | 78229 | — |
| Virginia Cancer Specialists, PC Dept.ofFairfax SC | Fairfax | Virginia | 22031 | — |
| Medical Oncology Associates, PS | Spokane | Washington | 99208 | — |
| Wenatchee Valley Medical Center Wenatchee Valley | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01528345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2016 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01528345 live on ClinicalTrials.gov.